• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房治疗后发生的继发性硬化性胆管炎:组织病理学鉴别诊断线索

Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis.

作者信息

Esposito Irene, Kubisova Andrea, Stiehl Adolf, Kulaksiz Hasan, Schirmacher Peter

机构信息

Institute of Pathology, Helmholtz Zentrum München-German Research Center for Environmental Health, Oberschleissheim, Germany.

出版信息

Virchows Arch. 2008 Oct;453(4):339-45. doi: 10.1007/s00428-008-0654-1. Epub 2008 Sep 4.

DOI:10.1007/s00428-008-0654-1
PMID:18769938
Abstract

Secondary sclerosing cholangitis (SSC) is a chronic cholestatic disorder caused by mechanical, infectious, toxic, or ischemic factors. A new variant of SSC occurring after long-term treatment in intensive care units (ICU) has been recently described and characterized from the clinical point of view. The aim of this study was the histomorphological characterization of ICU-treatment-related SSC (ICU-SSC) and the definition of histological changes occurring over time based on the morphological findings. Liver biopsies of ten patients affected by ICU-SSC obtained at different time points (1.5 to 57 months) after the initial injury were analyzed. The main morphological alterations included degenerative changes of portal bile ducts, portal edema, inflammation, and fibrosis as well as biliary interface activity and bilirubinostasis. Perivenular necroses and bile infarcts were found in eight and six patients, respectively. Bile duct loss was not observed. No correlation between morphological features of biopsies and liver chemistry tests or outcome could be established. Based on the morphological observation, a possible disease-progression model starting with an initial damage of portal bile ducts (primary insult) with associated portal/periportal changes (inflammation, ductular reaction) and resulting in secondary parenchymal changes is proposed.

摘要

继发性硬化性胆管炎(SSC)是一种由机械性、感染性、毒性或缺血性因素引起的慢性胆汁淤积性疾病。最近从临床角度描述并表征了一种在重症监护病房(ICU)长期治疗后出现的SSC新变体。本研究的目的是对ICU治疗相关的SSC(ICU-SSC)进行组织形态学表征,并根据形态学发现定义随时间发生的组织学变化。分析了10例受ICU-SSC影响的患者在初次损伤后不同时间点(1.5至57个月)获取的肝活检标本。主要形态学改变包括门静脉胆管的退行性改变、门静脉水肿、炎症和纤维化,以及胆管界面活性和胆红素淤积。分别在8例和6例患者中发现了小叶中央静脉周围坏死和胆汁梗死。未观察到胆管缺失。活检的形态学特征与肝脏化学检测或预后之间未发现相关性。基于形态学观察,提出了一种可能的疾病进展模型,该模型始于门静脉胆管的初始损伤(原发性损伤)并伴有相关的门静脉/门静脉周围改变(炎症、小胆管反应),进而导致继发性实质改变。

相似文献

1
Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis.重症监护病房治疗后发生的继发性硬化性胆管炎:组织病理学鉴别诊断线索
Virchows Arch. 2008 Oct;453(4):339-45. doi: 10.1007/s00428-008-0654-1. Epub 2008 Sep 4.
2
Secondary sclerosing cholangitis following major burn.大面积烧伤后继发性硬化性胆管炎
Ann Hepatol. 2015 Sep-Oct;14(5):695-701.
3
[Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].[肝穿刺活检和内镜逆行胆管造影在慢性无黄疸型不明原因胆汁淤积患者中的重要性。对79例患者的回顾性研究]
Gastroenterol Clin Biol. 1999 Feb;23(2):178-85.
4
Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.危重症患者中的缺血样胆管病伴继发性硬化性胆管炎
Am J Gastroenterol. 2007 Jun;102(6):1221-9. doi: 10.1111/j.1572-0241.2007.01118.x.
5
Sclerosing Cholangitis: Clinicopathologic Features, Imaging Spectrum, and Systemic Approach to Differential Diagnosis.硬化性胆管炎:临床病理特征、影像学表现及鉴别诊断的系统方法
Korean J Radiol. 2016 Jan-Feb;17(1):25-38. doi: 10.3348/kjr.2016.17.1.25. Epub 2016 Jan 6.
6
Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up.重症监护病房长期治疗后发生的继发性硬化性胆管炎:临床表现、内镜检查结果、治疗及随访
Endoscopy. 2006 Jul;38(7):730-4. doi: 10.1055/s-2006-925241.
7
[A contribution to the differential diagnostics of sclerosing cholangitides].[对硬化性胆管炎鉴别诊断的一项贡献]
Vnitr Lek. 2017 Winter;63(1):50-55.
8
Histopathology of cholestasis.胆汁淤积的组织病理学
Verh Dtsch Ges Pathol. 1995;79:233-40.
9
Secondary sclerosing cholangitis.继发性硬化性胆管炎
Nat Rev Gastroenterol Hepatol. 2009 May;6(5):287-95. doi: 10.1038/nrgastro.2009.46.
10
Sclerosing cholangitis: a focus on secondary causes.硬化性胆管炎:聚焦继发性病因。
Hepatology. 2006 Nov;44(5):1063-74. doi: 10.1002/hep.21405.

引用本文的文献

1
COVID-19-Related Cholangiopathy: Histological Findings.新型冠状病毒肺炎相关胆管病:组织学表现
Diagnostics (Basel). 2024 Aug 19;14(16):1804. doi: 10.3390/diagnostics14161804.
2
Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?新型冠状病毒肺炎后的继发性硬化性胆管炎:危重症患者在胆汁缺血情况下使用重症监护病房氯胺酮还是病毒特异性胆管嗜性及损伤?
Hepat Med. 2023 Aug 1;15:93-112. doi: 10.2147/HMER.S384220. eCollection 2023.
3
Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19.

本文引用的文献

1
Poor outcome in progressive sclerosing cholangitis after septic shock.感染性休克后进行性硬化性胆管炎预后不良。
Endoscopy. 2008 Mar;40(3):214-8. doi: 10.1055/s-2007-967024. Epub 2008 Feb 11.
2
Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis.免疫球蛋白G4相关性肝病:肝脏中携带免疫球蛋白G4的浆细胞与自身免疫性胰腺炎的关联。
Hepatology. 2007 Aug;46(2):463-71. doi: 10.1002/hep.21700.
3
Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature.
COVID-19 患者长期使用氯胺酮后肝胆汁淤积生物标志物的特征。
BMC Anesthesiol. 2023 Feb 7;23(1):44. doi: 10.1186/s12871-023-02006-2.
4
Secondary sclerosing cholangitis in a young COVID-19 patient resulting in death: A case report.一名年轻的新冠病毒肺炎患者继发硬化性胆管炎并导致死亡:病例报告
World J Gastrointest Surg. 2022 Dec 27;14(12):1411-1417. doi: 10.4240/wjgs.v14.i12.1411.
5
Meta-analysis and systematic review of liver transplantation as an ultimate treatment option for secondary sclerosing cholangitis.肝移植作为继发性硬化性胆管炎最终治疗选择的Meta分析和系统评价
Prz Gastroenterol. 2022;17(1):1-8. doi: 10.5114/pg.2021.110483. Epub 2021 Nov 1.
6
Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19.继发硬化性胆管炎是重症 COVID-19 患者持续性黄疸的病因。
Liver Int. 2021 Oct;41(10):2404-2417. doi: 10.1111/liv.14971. Epub 2021 Jul 4.
7
Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report.新冠病毒感染后胆管病——肝移植的新适应证:病例报告。
Transplant Proc. 2021 May;53(4):1132-1137. doi: 10.1016/j.transproceed.2021.03.007. Epub 2021 Mar 12.
8
Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.危重症患者的继发性硬化性胆管炎:一种诊断不足的疾病。
GE Port J Gastroenterol. 2020 Feb;27(2):103-114. doi: 10.1159/000501405. Epub 2019 Jul 30.
9
Secondary sclerosing cholangitis in critically ill patients: current perspectives.危重症患者的继发性硬化性胆管炎:当前观点
Clin Exp Gastroenterol. 2017 Jun 23;10:105-111. doi: 10.2147/CEG.S115518. eCollection 2017.
10
Secondary sclerosing cholangitis in a critically ill patient.一名危重症患者的继发性硬化性胆管炎
Quant Imaging Med Surg. 2016 Apr;6(2):224-8. doi: 10.21037/qims.2016.04.04.
免疫球蛋白G4相关性胆管炎:基于文献综述对一种新出现的临床实体的描述
Hepatology. 2007 Jun;45(6):1547-54. doi: 10.1002/hep.21685.
4
Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.危重症患者中的缺血样胆管病伴继发性硬化性胆管炎
Am J Gastroenterol. 2007 Jun;102(6):1221-9. doi: 10.1111/j.1572-0241.2007.01118.x.
5
Sclerosing cholangitis.硬化性胆管炎
Curr Opin Gastroenterol. 2007 May;23(3):310-6. doi: 10.1097/MOG.0b013e32805867e6.
6
Sclerosing cholangitis: a focus on secondary causes.硬化性胆管炎:聚焦继发性病因。
Hepatology. 2006 Nov;44(5):1063-74. doi: 10.1002/hep.21405.
7
Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.疾病机制:脓毒症中胆汁淤积的机制及临床意义
Nat Clin Pract Gastroenterol Hepatol. 2006 Oct;3(10):574-85. doi: 10.1038/ncpgasthep0602.
8
Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up.重症监护病房长期治疗后发生的继发性硬化性胆管炎:临床表现、内镜检查结果、治疗及随访
Endoscopy. 2006 Jul;38(7):730-4. doi: 10.1055/s-2006-925241.
9
Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms.严重创伤后硬化性胆管炎:一种值得关注的疾病实体描述,重点探讨可能的病理生理机制。
World J Gastroenterol. 2005 Jul 21;11(27):4199-205. doi: 10.3748/wjg.v11.i27.4199.
10
Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders.感染性休克后进行性硬化性胆管炎:一种新型的胆管消失性疾病。
Gut. 2003 May;52(5):688-93. doi: 10.1136/gut.52.5.688.